This does not undermine the findings of this study
All of our peptide therapy is provider-supervised and begins with a medical evaluation, and we source from licensed compounding pharmacies
Licensed for BMI 30 kg/m or 28 kg/m with comorbidities Naltrexone-bupropion combination (Mysimba) : Licensed in the UK but with limited NHS availability as NICE terminated its technology appraisal
They work by regulating appetite, improving fat metabolism, enhancing energy use, and preserving lean muscle
This effect attenuates postprandial glucose excursions, though tachyphylaxis (reduced response over time) to this particular effect may occur with chronic GLP-1 receptor agonist therapy
Because they're not making products for human consumption, they're not subject to rules about what they can offer and when, based on shortages, drug approvals, or patent status